Bank of America’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.2M | Buy |
1,082,671
+291,859
| +37% | +$9.49M | ﹤0.01% | 1752 |
|
|
2025
Q1 | $29.9M | Buy |
790,812
+320,901
| +68% | +$12.1M | ﹤0.01% | 1783 |
|
|
2024
Q4 | $38.5M | Sell |
469,911
-99,979
| -18% | -$8.18M | ﹤0.01% | 1475 |
|
|
2024
Q3 | $65.1M | Buy |
569,890
+98,609
| +21% | +$11.3M | 0.01% | 1191 |
|
|
2024
Q2 | $35.6M | Buy |
471,281
+185,405
| +65% | +$14M | ﹤0.01% | 1527 |
|
|
2024
Q1 | $19.5M | Buy |
285,876
+111,725
| +64% | +$7.63M | ﹤0.01% | 2001 |
|
|
2023
Q4 | $10.9M | Sell |
174,151
-35,982
| -17% | -$2.26M | ﹤0.01% | 2333 |
|
|
2023
Q3 | $10.7M | Sell |
210,133
-30,970
| -13% | -$1.58M | ﹤0.01% | 2253 |
|
|
2023
Q2 | $12M | Sell |
241,103
-43,006
| -15% | -$2.15M | ﹤0.01% | 2151 |
|
|
2023
Q1 | $10.6M | Sell |
284,109
-12,510
| -4% | -$469K | ﹤0.01% | 2363 |
|
|
2022
Q4 | $14.2M | Buy |
296,619
+190,164
| +179% | +$9.12M | ﹤0.01% | 1996 |
|
|
2022
Q3 | $2.56M | Buy |
106,455
+10,151
| +11% | +$244K | ﹤0.01% | 3451 |
|
|
2022
Q2 | $2.1M | Buy |
96,304
+57,826
| +150% | +$1.26M | ﹤0.01% | 3669 |
|
|
2022
Q1 | $929K | Sell |
38,478
-36,589
| -49% | -$883K | ﹤0.01% | 4674 |
|
|
2021
Q4 | $1.79M | Buy |
75,067
+46,834
| +166% | +$1.11M | ﹤0.01% | 4009 |
|
|
2021
Q3 | $716K | Sell |
28,233
-50,378
| -64% | -$1.28M | ﹤0.01% | 4592 |
|
|
2021
Q2 | $1.77M | Buy |
78,611
+29,344
| +60% | +$661K | ﹤0.01% | 3829 |
|
|
2021
Q1 | $973K | Buy |
49,267
+45,741
| +1,297% | +$903K | ﹤0.01% | 4273 |
|
|
2020
Q4 | $93K | Sell |
3,526
-179
| -5% | -$4.72K | ﹤0.01% | 5285 |
|
|
2020
Q3 | $183K | Buy |
3,705
+3,505
| +1,753% | +$173K | ﹤0.01% | 4751 |
|
|
2020
Q2 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 5927 |
|